title: Organizational effects of estrogen on male-type vulnerability to early weaning.
abstract: We previously reported that early-weaned (postnatal day 14) male ICR mice, compared to normally weaned animals, exhibited a persistent increase in anxiety-related behavior in the elevated plus maze test. In this study, we examined whether steroid hormone manipulations on postnatal day 0 and at the ages of 2 or 3 weeks affected male-type vulnerability to early weaning. Neither castration nor ovariectomy at the age of 3 weeks affected male-type vulnerability. However, in males, castration at the age of 2 weeks attenuated the increased anxiety levels induced by early weaning, and the implantation of testosterone or estradiol, but not of dihydrotestosterone, restored the effects of early weaning. In contrast, in females, neonatal treatment with testosterone propionate together with testosterone at the age of 2 weeks, which reversed sexual behavior to the male type, did not affect anxiety levels in response to early weaning. When pregnant females were repeatedly treated with testosterone propionate on embryonic days 14, 17, and 19, in addition to testosterone treatment at the age of 2 weeks, the anxiety levels in female were increased by early weaning. Furthermore, the prenatal treatment of estradiol benzoate, but not dihydrotestosterone, induced enhanced anxiety levels by early weaning in females. These results suggest that neural systems are masculinized by estrogen from the embryonic phase to the early postnatal period and are responsible for the high levels of anxiety elicited by early weaning.
authors: Companion Animal Research, School of Veterinary Medicine, Azabu University, 1-17-71, Fuchinobe, Chuo-ku, Sagamihara, Kanagawa 252-5201, Japan. kikusui@azabu-u.ac.jp
authors: Takefumi
authors: T
authors: Kikusui
authors: Yuko
authors: Y
authors: Shimokawa
authors: Natsumi
authors: N
authors: Kanbara
authors: Miho
authors: M
authors: Nagasawa
authors: Kazutaka
authors: K
authors: Mogi
mesh_terms: D000818:Animals; D001007:Anxiety / Q000523:psychology*; D001522:Behavior, Animal / Q000187:drug effects*; D013196:Dihydrotestosterone / Q000008:administration & dosage / Q000494:pharmacology; D004343:Drug Implants; D004958:Estradiol / Q000008:administration & dosage / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology*; D005106:Exploratory Behavior / Q000502:physiology; D005260:Female; D008297:Male; D008426:Maternal Deprivation; D051379:Mice; D008813:Mice, Inbred ICR; D009919:Orchiectomy; D010052:Ovariectomy; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D013256:Steroids / Q000494:pharmacology; D013739:Testosterone / Q000008:administration & dosage / Q000494:pharmacology; D014886:Weaning
chemical_list: D004343:Drug Implants; D004967:Estrogens; D013256:Steroids; D013196:Dihydrotestosterone; D013739:Testosterone; D004958:Estradiol